BioCryst Pharmaceuticals Inc. (BO1)
Market Closed
3 Jun, 20:00
XSTU 
€
7. 0220
-0.108
-1.51%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
-0.62 Eps
€ 7.13
Previous Close Want to track BO1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.11 | - |
| | | 0.07 | - |
| | | 0.08 | - |
| | | 0.03 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
BO1 Earnings Reports FAQ
What is the earnings per share (EPS) for BO1?
The current EPS is -0.62.
What is the company's earnings growth rate?
BioCryst Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
BioCryst Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for BioCryst Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for BO1 at this time, as BioCryst Pharmaceuticals Inc has no recent EPS data to calculate it.
